Ohio-based Jet Edge has entered into an agreement with Cue Health to provide all its flight crews and global teams routine access to real-time COVID-19 molecular self-testing with instant results. Jet Edge is the first private aircraft operator to adopt a molecular self-testing solution.

“Cue's breakthrough testing technology allows Jet Edge to further our commitment to the health and safety of our passengers and crews,” says CCO Jonah Adler. “Rather than relying on ever-changing messages from guideline groups, we are now giving each of our employees their own Cue reader and cartridge for daily testing. Their results are fast and actionable. Knowing who is positive and negative each morning greatly lessens our logistical challenges and keeps our passengers and employees even safer.”

The Cue test uses nucleic acid amplification technology to provide lab-quality COVID-19 test results from any location in 20 minutes. Based on current clinical studies submitted to the FDA, it is the most accurate self-test for COVID-19 and can detect all known COVID-19 variants, including Omicron. Cue's lab results are directly connected to mobile devices so that critical safety information can be easily accessed and acted on immediately. The test can be used on adults and children over two years, with or without symptoms.

“We are proud to help meet the unique testing needs of Jet Edge. The Cue Health Enterprise Dashboard shares test results through a secure, web-based internal application which gives Jet Edge proprietary, timely analytics to swiftly identify trends and make informed safety decisions,” adds Cue Health chief strategy officer Chris Achar. “With the widely adaptable Cue solution, we can help alleviate the pressures on local testing providers and healthcare systems.”